ConductScience.org, home

Paper427730

Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.

Balch CM and 5 others. Cancer, 1979. Cited by 323 papers, by iCite.

Cite this record

ConductScience Library. Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Papers, record 427730. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/427730

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients.
PubMed
Journal
Cancer
PubMed
Year
1979
PubMed
Publication types
Journal Article, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
323
iCite
Relative citation ratio, by iCite
16.2
iCite
Revised in PubMed
2019-06-19
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Balch CMC M
2Murad TMT M
3Soong SJS J
4Ingalls ALA L
5Richards PCP C
6Maddox WAW A

Source PubMed

Download CSV of authors

Topics7

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
MelanomaMajor topic
Skin NeoplasmsMajor topic
Humans
Lymph Node Excision
Neoplasm Metastasis
Neoplasm Recurrence, Local
Neoplasm Staging

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 323 citations.

PMIDTitleJournalYearIn PapersSource
36811735Commentary re PRADO: De-escalation in Melanoma After Neoadjuvant Therapy: When to Cut and When to Cut Back.Ann Surg Oncol2023https://conductscience.org/library/papers/36811735PubMed
35591818Re-excision within a radius of 2 cm in patients with melanoma of the skin - sufficient for local oncological radicalness.Arch Med Sci2022https://conductscience.org/library/papers/35591818PubMed
30232648Sentinel Lymph Node Biopsy and Completion Lymph Node Dissection for Melanoma.Curr Treat Options Oncol2018https://conductscience.org/library/papers/30232648PubMed
26586498Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma.Ann Surg Oncol2016https://conductscience.org/library/papers/26586498PubMed
24521106Final trial report of sentinel-node biopsy versus nodal observation in melanoma.N Engl J Med2014https://conductscience.org/library/papers/24521106PubMed
24340152Treatment outcomes of advanced stage malignant melanoma in hand and foot after amputation in Korean patients.Clin Orthop Surg2013https://conductscience.org/library/papers/24340152PubMed
21748656MRI-derived tumor thickness: an important predictor of outcome for T4a-staged tongue carcinoma.Eur Arch Otorhinolaryngol2012https://conductscience.org/library/papers/21748656PubMed
20689737Choroidal pigmented lesions imaged by ultra-wide-field scanning laser ophthalmoscopy with two laser wavelengths (Optomap).Clin Ophthalmol2010https://conductscience.org/library/papers/20689737PubMed
16633005Gender-related differences in outcome for melanoma patients.Ann Surg2006https://conductscience.org/library/papers/16633005PubMed
11122858Surgical management of primary melanoma.Curr Oncol Rep2000https://conductscience.org/library/papers/11122858PubMed
9462499A biopsy is more than a biopsy.J Gen Intern Med1998https://conductscience.org/library/papers/9462499PubMed
8813254Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger.Ann Surg1996https://conductscience.org/library/papers/8813254PubMed
8373269Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.Ann Surg1993https://conductscience.org/library/papers/8373269PubMed
8129491Surgical management and prognostic factors in patients with subungual melanoma.Ann Surg1994https://conductscience.org/library/papers/8129491PubMed
7850524Groin dissection in malignant melanoma.Ann Surg Oncol1994https://conductscience.org/library/papers/7850524PubMed
7352783Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.Ann Surg1980https://conductscience.org/library/papers/7352783PubMed
7212800A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II).Ann Surg1981https://conductscience.org/library/papers/7212800PubMed
7149819A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia.Ann Surg1982https://conductscience.org/library/papers/7149819PubMed
7104199Cutaneous malignant melanoma in Scotland.Br J Cancer1982https://conductscience.org/library/papers/7104199PubMed
7092355Factors prognostic for survival in patients with malignant melanoma spread to the regional lymph nodes.Ann Surg1982https://conductscience.org/library/papers/7092355PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/427730

GET https://conductscience.org/api/papers/v1/427730/cited_by?page=2